Helping people survive cancer requires an ongoing and everlasting commitment to collaboration.
From the academic research that fuels our product development and commercialization activities, to a corporate social responsibility to support the clinical and educational missions of patient, diagnostic, treatment, regulatory and payer organizations, Preora Healthcare embraces the value inherent in strong partnerships.
Through current and future partnerships and collaborations, Preora Healthcare will empower organizations to further expand the potential applications for PWS NanocytologyTM, resulting in new tools for physicians, cytologists, cytopathologists and researchers to deploy in the battle against cancer.